A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine

Viatris

Status and phase: Completed; Phase 4

Conditions: Migraine

Treatments: Drug: eletriptan

Study type: Interventional

Funder types: Industry

Identifiers

NCT00174395

A1601107

Details and patient eligibility

About

To evaluate the efficacy of early intervention (dosing within 2 hours of onset of the migraine attack) with eletriptan 40mg on mild versus moderate to severe pain intensity of migraine.

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of migraine with or without aura according to the recent IHS criteria.
• Migraine headaches must have been present for more than one year.
• History in the last 3 months of 1 to 4 acute attacks of migraine headache per month.

Exclusion criteria

• Subjects with current or past history of coronary artery disease.
• Pregnant or breastfeeding women.
• Subjects who have chronic daily headaches.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)